{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:56:10Z","timestamp":1784735770606,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.numecd.2014.08.008","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T14:32:04Z","timestamp":1411137124000},"page":"181-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Uric acid levels and the risk of Contrast Induced Nephropathy in\u00a0patients undergoing coronary angiography or PCI"],"prefix":"10.1016","volume":"25","author":[{"given":"L.","family":"Barbieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Verdoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Suryapranata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2014.08.008_bib1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","article-title":"Contrast-induced acute kidney injury","volume":"51","author":"McCullough","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2014.08.008_bib2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ki.2010.258","article-title":"Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function","volume":"78","author":"James","year":"2010","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.numecd.2014.08.008_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ccc.2004.12.003","article-title":"Contrast-induced nephropathy","volume":"21","author":"McCullough","year":"2005","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.numecd.2014.08.008_bib4","first-page":"1393","article-title":"A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2014.08.008_bib5","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jacc.2004.06.075","article-title":"Contrast nephropathy: review focusing on prevention","volume":"44","author":"Maeder","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2014.08.008_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4244\/EIJV7I8A155","article-title":"Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials","volume":"7","author":"Navarese","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.numecd.2014.08.008_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/archinternmed.2012.758","article-title":"Drug-eluting stent in primary angioplasty (DESERT) cooperation. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"172","author":"De Luca","year":"2012","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.numecd.2014.08.008_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijcard.2011.11.102","article-title":"A meta-analytic overview of thrombectomy during primary angioplasty","volume":"166","author":"De Luca","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2014.08.008_bib9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.atherosclerosis.2012.02.041","article-title":"Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials","volume":"222","author":"De Luca","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2014.08.008_bib10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1160\/TH04-11-0726","article-title":"Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction","volume":"93","author":"De Luca","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.numecd.2014.08.008_bib11","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/j.1538-7836.2011.04445.x","article-title":"Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis","volume":"9","author":"Navarese","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.numecd.2014.08.008_bib12","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1097\/00004424-198011001-00014","article-title":"Tubular nephrotoxicity of water-soluble iodinated contrast media","volume":"15","author":"Moreau","year":"1980","journal-title":"Invest Radiol"},{"key":"10.1016\/j.numecd.2014.08.008_bib13","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1503\/cmaj.1040847","article-title":"Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies","volume":"172","author":"Goldenberg","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.numecd.2014.08.008_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijcard.2008.06.024","article-title":"Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience","volume":"138","author":"Lazzeri","year":"2010","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2014.08.008_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/0003319712463816","article-title":"Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"65","author":"Elbasan","year":"2014","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.numecd.2014.08.008_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3109\/0886022X.2011.653753","article-title":"New insights into uric acid effects on the progression and prognosis of chronic kidney disease","volume":"34","author":"Filiopoulus","year":"2012","journal-title":"Ren Fail"},{"issue":"2 Suppl. 1","key":"10.1016\/j.numecd.2014.08.008_bib17","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.numecd.2014.08.008_bib18","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/eurheartj\/ehi110","article-title":"Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty","volume":"26","author":"De Luca","year":"2005","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.numecd.2014.08.008_bib19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pcad.2007.11.004","article-title":"Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status","volume":"50","author":"De Luca","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2014.08.008_bib20","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1538-7836.2011.04513.x","article-title":"Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis","volume":"9","author":"De Luca","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"Suppl.","key":"10.1016\/j.numecd.2014.08.008_bib21","doi-asserted-by":"crossref","first-page":"27K","DOI":"10.1016\/j.amjcard.2006.01.022","article-title":"Risk prediction of contrast induced nephropathy","volume":"98","author":"McCullough","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2014.08.008_bib22","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.ahj.2010.09.022","article-title":"Acute hyperglycemia and contrast induced nephropathy in primary percutaneous coronary intervention","volume":"160","author":"Marenzi","year":"2010","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.numecd.2014.08.008_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semnephrol.2004.10.001","article-title":"Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease","volume":"25","author":"Kang","year":"2005","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.numecd.2014.08.008_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0021-9150(99)00214-2","article-title":"Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?","volume":"148","author":"Nieto","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2014.08.008_bib25","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.2337\/db06-0283","article-title":"Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers","volume":"55","author":"Waring","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2014.08.008_bib26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.numecd.2010.08.005","article-title":"Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study","volume":"22","author":"De Luca","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.numecd.2014.08.008_bib27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-74-6-845","article-title":"Uricosuric effect of radiocontrast agents. A study in man of four commonly used preparations","volume":"74","author":"Postlethwaite","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2014.08.008_bib28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM197104292841701","article-title":"Uricosuric action of cholecystographic agents: possible nephrotoxicity","volume":"284","author":"Mudge","year":"1971","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.numecd.2014.08.008_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ccd.20598","article-title":"Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease","volume":"67","author":"Toprak","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.numecd.2014.08.008_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajem.2013.10.011","article-title":"Relation of uric acid and contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED","volume":"32","author":"Saritemur","year":"2013","journal-title":"Am J Emerg Med"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475314002816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475314002816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T05:28:39Z","timestamp":1565846919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475314002816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0939475314002816"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2014.08.008","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uric acid levels and the risk of Contrast Induced Nephropathy in\u00a0patients undergoing coronary angiography or PCI","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2014.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}